PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma. - Mittlmeier, L. M.; Unterrainer, M.; Todica, A.; Cyran, C. C.; Rodler, S.; Bartenstein, P.; Stief, C. G.; Ilhan, H.; Staehler, M. (European Journal of Nuclear Medicine & Molecular Imaging, 2020)